Reza Halse

Reza Halse is a Partner at RA Capital Management, where he directs early-stage life sciences and biotechnology investments with a specialized emphasis on novel oncology therapeutics. He brings over 25 years of executive leadership experience across the global pharmaceutical and biotech sectors, primarily specializing in therapeutic discovery, clinical development, and translational research. In addition to his core investment responsibilities, he currently serves as the President of CinRx and holds a strategic board seat at Adcendo, a biotechnology firm developing antibody-drug conjugates for targeted cancer treatment. Through his various board and advisory capacities, he frequently collaborates with prominent life sciences investment syndicates, including Novo Seeds and HealthCap, to advance early-stage clinical pipelines and drug discovery programs. His professional background and current investment focus remain centered on identifying, funding, and scaling innovative biopharmaceutical companies that are pioneering next-generation therapeutic modalities.